Corcept Therapeutics Incorporated

Corcept Therapeutics Incorporatedverified

0I3Q.L

Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients with endogenous Cushing's syndrome, who have type 2 diabetes mellitus or glucose intolerance, and have failed surgery or are not candidates for surgery. It is developing relacorilant to treat patients with Cushing's syndrome; and nab-paclitaxel in combination with relacorilant, which has completed Phase II clinical trial to treat patients with advance...[Read more]

Industry

Medical - Pharmaceuticals

IPO Date

2018-01-29

Stock Exchange

LSE

Ticker

0I3Q.L

The Enterprise Value as of November 2025 (TTM) for Corcept Therapeutics Incorporated (0I3Q.L) is 7.64B

According to Corcept Therapeutics Incorporated’s latest financial reports and current stock price. The company's current Enterprise Value is 7.64B. This represents a change of -7.28% compared to the average of 8.24B of the last 4 quarters.

Corcept Therapeutics Incorporated (0I3Q.L) Historical Enterprise Value (quarterly & annually)

How has 0I3Q.L Enterprise Value performed in the past?

The mean historical Enterprise Value of Corcept Therapeutics Incorporated over the last ten years is 2.03B. The current 7.64B Enterprise Value has changed 37.51% with respect to the historical average. Over the past ten years (40 quarters), 0I3Q.L's Enterprise Value was at its highest in in the March 2025 quarter at 11.81B. The Enterprise Value was at its lowest in in the March 2016 quarter at 488.79M.

Quarterly (TTM)
Annual

Average

2.03B

Median

1.84B

Minimum

506.39M

Maximum

5.08B

Corcept Therapeutics Incorporated (0I3Q.L) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Corcept Therapeutics Incorporated Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 154.14%

Maximum Annual Enterprise Value = 5.08B

Minimum Annual Increase = -27.21%

Minimum Annual Enterprise Value = 506.39M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
20245.08B57.40%
20233.23B86.24%
20221.73B-11.32%
20211.95B-23.19%
20202.54B137.44%
20191.07B-27.21%
20181.47B-24.35%
20171.95B154.14%
2016765.84M51.23%
2015506.39M75.76%

Corcept Therapeutics Incorporated (0I3Q.L) Average Enterprise Value

How has 0I3Q.L Enterprise Value performed in the past?

The current Enterprise Value of Corcept Therapeutics Incorporated (0I3Q.L) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

3.35B

5-year avg

2.91B

10-year avg

2.03B

Corcept Therapeutics Incorporated (0I3Q.L) Enterprise Value vs. Peers

How is 0I3Q.L’s Enterprise Value compared to its peers?

Corcept Therapeutics Incorporated’s Enterprise Value is less than Halozyme Therapeutics, Inc. (9.12B), less than Masimo Corporation (7.97B), greater than Axsome Therapeutics, Inc. (6.86B), less than Henry Schein, Inc. (12.03B), less than Exelixis, Inc. (10.74B), less than DaVita Inc. (20.31B), greater than TG Therapeutics, Inc. (5.24B), less than BioMarin Pharmaceutical Inc. (9.23B), greater than Viking Therapeutics, Inc. (4.06B), less than Baxter International Inc. (17.24B),

Build a custom stock screener for Corcept Therapeutics Incorporated (0I3Q.L) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Corcept Therapeutics Incorporated using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Corcept Therapeutics Incorporated (0I3Q.L) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Corcept Therapeutics Incorporated or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Corcept Therapeutics Incorporated's Enterprise Value?

What is the highest Enterprise Value for Corcept Therapeutics Incorporated (0I3Q.L)?

What is the 3-year average Enterprise Value for Corcept Therapeutics Incorporated (0I3Q.L)?

What is the 5-year average Enterprise Value for Corcept Therapeutics Incorporated (0I3Q.L)?

How does the current Enterprise Value for Corcept Therapeutics Incorporated (0I3Q.L) compare to its historical average?